MIBG
Updates to Article Attributes
Body
was changed:
MIBG scan is a scintigraphic study that uses metaiodobenzylguanidine labeled to iodine-123 or iodine-131. It is indicated in the investigation of phaeochromocytoma.
MIBG is positive in:
- neuroblastoma
- carcinoid tumour 4
- paraganglioma
- medullary thyroid carcinoma
- ganglioneuroma
- ganglioneuroblastoma
Some mild uptake can be physiologic in 4:
- liver
- salivary glands
- urinary bladder
- heart
- gastrointestinal tract
- adrenal glands
- brown fat
-<p><strong>MIBG scan</strong> is a scintigraphic study that uses metaiodobenzylguanidine labeled to <a href="/articles/iodine-123">iodine-123</a> or <a href="/articles/i-131">iodine-131</a>. It is indicated in the investigation of <a href="/articles/pheochromocytoma-2">phaeochromocytoma</a>.</p><p>MIBG is positive in:</p><ul>- +<p><strong>MIBG scan</strong> is a scintigraphic study that uses metaiodobenzylguanidine labeled to <a href="/articles/iodine-123">iodine-123</a> or <a href="/articles/iodine-131-2">iodine-131</a>. It is indicated in the investigation of <a href="/articles/phaeochromocytoma-1">phaeochromocytoma</a>.</p><p>MIBG is positive in:</p><ul>
-<a href="/articles/carcinoid-tumours-1">carcinoid tumour </a><sup>4</sup>- +<a href="/articles/carcinoid-tumour-2">carcinoid tumour </a><sup>4</sup>
Images Changes:
Image 2 Nuclear medicine (MIBG scintigraphy) ( create )
Unable to process the form. Check for errors and try again.